| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |